We are live on ! Find out more
TRV

Third Rock Ventures Portfolio holdings

AUM $1.07B
1-Year Est. Return 170.23%
This Fund
S&P 500
This Quarter Est. Return
+52.99%
1 Year Est. Return
+170.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.22B
AUM Growth
+$365M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGE
1
DELISTED
Sage Therapeutics
SAGE
$428M 34.97%
11,681,008
AGIO icon
2
Agios Pharmaceuticals
AGIO
$2.38B
$344M 28.13%
3,070,090
LRMR icon
3
Larimar Therapeutics
LRMR
$398M
$173M 14.13%
466,837
BLUE
4
DELISTED
bluebird bio
BLUE
$111M 9.11%
93,802
FMI
5
DELISTED
Foundation Medicine, Inc.
FMI
$109M 8.95%
4,927,234
CARM
6
DELISTED
Carisma Therapeutics
CARM
$57.5M 4.7%
242,080

Similar funds

Third Rock Ventures's Q4 2014 Portfolio in Review

As of Q4 2014, Third Rock Ventures held 6 positions worth $1.22B, up 43% from $857M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. Third Rock Ventures opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Third Rock Ventures's ten largest holdings make up 100% of its $1.22B portfolio in Q4 2014.
  • Third Rock Ventures opened 0 new positions and closed 0 in Q4 2014.
  • Third Rock Ventures's portfolio value rose 43% quarter-over-quarter to $1.22B.

Based on Third Rock Ventures's 13F filing for Q4 2014, filed 26 Jan 2015.